blonanserin has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, T; Hibi, S; Kito, S; Koga, Y; Mochida, M; Nakajima, T; Tobe, Y | 1 |
| Anai, K; Arai, J; Funamoto, Y; Ito, Y; Kaneda, Y; Kitajima, R; Miyake, N; Miyamoto, S; Ogino, S; Ojima, K; Sumiyoshi, T; Tadokoro, M; Tenjin, T; Teramoto, H; Tsukahara, S; Yamaguchi, N | 1 |
1 trial(s) available for blonanserin and Chronic Illness
| Article | Year |
|---|---|
Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chronic Disease; Cognition Disorders; Female; Humans; Male; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Young Adult | 2012 |
1 other study(ies) available for blonanserin and Chronic Illness
| Article | Year |
|---|---|
Successful treatment with blonanserin for drug-induced hyperprolactinemia in chronic schizophrenia patients: a six-month follow-up of two cases.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Middle Aged; Piperazines; Piperidines; Prolactin; Schizophrenia | 2013 |